Substance / Medication

Tolterodine

Overview

Active Ingredient
tolterodine
RxNorm CUI
119565

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Tolterodine extended release in the treatment of male OAB/storage LUTS: a systematic review.
Gacci Mauro, Novara Giacomo, De Nunzio Cosimo et al. · BMC Urol · 2014
PMID: 25348235Meta-AnalysisFull text (PMC)
[Safety of solifenacin and tolterodine in the treatment of overactive bladder: a meta-analysis].
Xu Chao, Jiang Xian-zhou, Zhang Nian-zhao et al. · Zhonghua Yi Xue Za Zhi · 2012
PMID: 23327698Meta-Analysis
Tolterodine extended release is well tolerated in older subjects.
Griebling T L, Kraus S R, Richter H E et al. · Int J Clin Pract · 2009
PMID: 19624787Meta-AnalysisFull text (PMC)
Desmopressin Plus Tolterodine vs Desmopressin Plus Indomethacin for Refractory Pediatric Enuresis: An Open-label Randomized Controlled Trial.
Esteghamati Maryam, Mousavi Seyedeh Elaheh, Zoghi Ghazal · Indian Pediatr · 2023
PMID: 37078485RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Tolterodine (substance)
SNOMED CT
372570008
UMLS CUI
C0388753
RxNorm CUI
119565

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.